Almirol, James C.
HRN: 26-61-00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/24/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/24/2025
01/31/2025
IV
500MG
Q8H
APPENDICITIS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes